Digital Therapeutics Market
完整報告名稱與涵蓋範圍
Digital Therapeutics Market Size, Share & Trends Analysis Report, By Application (Diabetes & Obesity, Mental Health & Behavioral Disorders, Musculoskeletal Rehabilitation, Substance Use Disorders, Respiratory & Cardiovascular Disease, Other Applications), By Sales Channel (Business-to-Business (Payers, Employers & Providers), Business-to-Consumer), By Platform, By Region, and Segment Forecasts, 2026-2035
報告摘要
Digital therapeutics are software-delivered interventions that prevent, manage or treat disease through clinically validated mechanisms, most commonly cognitive behavioural therapy protocols, structured coaching, sensor-guided exercise therapy and connected-device feedback loops. The market spans prescription and non-prescription products across metabolic disease, mental and behavioural health, musculoskeletal rehabilitation, substance use, and respiratory and cardiovascular management, sold through payer, employer, provider and pharmaceutical channels as well as directly to consumers.
Demand is rooted in capacity gaps that conventional care cannot close: behavioural health clinician shortages leave conditions such as insomnia, anxiety and depression undertreated, while diabetes, obesity and chronic back pain require daily behaviour change that episodic visits cannot supply. Employers and health plans buy programmes to bend pharmacy and surgical spend, a logic strengthened by GLP-1 therapy costs that make companion behavioural programmes attractive for adherence and lifestyle support. Reimbursement remains the structural hinge; Germany's DiGA pathway established a national listing-and-pricing template, and emerging prescription digital therapeutic payment mechanisms in the United States and Japan are gradually widening covered access. The sector has also consolidated sharply after a funding correction, rewarding companies with hard outcomes data and enterprise distribution over direct-to-consumer burn.
North America contributes the largest revenue through employer and payer channels, Europe advances on statutory reimbursement frameworks, and Asia Pacific develops through Japanese approvals and regional wellness ecosystems. Competition features musculoskeletal and metabolic category leaders, behavioural health specialists and pharma partnerships, with clinical evidence depth as the primary moat.
The InsightAce study delivers revenue forecasts in US$ across all segments and regions for 2026-2035, segment-level trend analysis, competitive landscape assessment and company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Therapeutics Market Snapshot
Chapter 4. Global Digital Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis
5.1. Application & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
5.2.1. Diabetes & Obesity
5.2.2. Mental Health & Behavioral Disorders
5.2.3. Musculoskeletal Rehabilitation
5.2.4. Substance Use Disorders
5.2.5. Respiratory & Cardiovascular Disease
5.2.6. Other Applications
Chapter 6. Market Segmentation 2: By Sales Channel Estimates & Trend Analysis
6.1. Sales Channel & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Sales Channel:
6.2.1. Business-to-Business (Payers, Employers & Providers)
6.2.2. Business-to-Consumer
Chapter 7. Market Segmentation 3: By Platform Estimates & Trend Analysis
7.1. Platform & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Platform:
7.2.1. Mobile Applications
7.2.2. Web-Based & Connected Device-Enabled Programs
Chapter 8. Digital Therapeutics Market: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Southeast Asia
8.3.7. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Omada Health
10.2. Hinge Health
10.3. Sword Health
10.4. Teladoc Health
10.5. Welldoc
10.6. DarioHealth
10.7. Big Health
10.8. Click Therapeutics
10.9. Kaia Health
10.10. Sidekick Health
10.11. CureApp
10.12. Freespira
10.13. Mahana Therapeutics
10.14. GAIA
圖表清單 List of Tables & Figures
Table 1. Global Digital Therapeutics Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 1. Digital Therapeutics Landscape: Prescription and Non-Prescription Segments
Table 2. Global Digital Therapeutics Revenue Forecast by Sales Channel, 2026-2035 (US$ Mn)
Figure 2. Global Digital Therapeutics Share by Application, 2026 & 2035
Table 3. Global Digital Therapeutics Revenue Forecast by Platform, 2026-2035 (US$ Mn)
Figure 3. Payer, Employer and Pharma Channel Economics Compared
Table 4. North America Digital Therapeutics Revenue by Country, 2026-2035 (US$ Mn)
Figure 4. Reimbursement Pathways: DiGA and Prescription Digital Therapeutic Frameworks
Table 5. Europe Digital Therapeutics Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Clinical Evidence Generation and Regulatory Clearance Trends
Table 6. Asia Pacific Digital Therapeutics Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Digital Therapeutics Growth Opportunity Analysis
Table 7. Latin America and Middle East & Africa Digital Therapeutics Revenue, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Digital Therapeutics Companies
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們